Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Hepatitis B virus infection.

Lee WM.

N Engl J Med. 1997 Dec 11;337(24):1733-45. Review. No abstract available.

PMID:
9392700
2.

Hepatitis B.

Befeler AS, Di Bisceglie AM.

Infect Dis Clin North Am. 2000 Sep;14(3):617-32. Review.

PMID:
10987113
4.

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.

Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G.

N Engl J Med. 1999 Jul 1;341(1):22-6.

5.

Treatment of HBV-related liver disease in the dialysis population: reality and promises.

Fabrizi F, Lunghi G, Martin P.

Int J Artif Organs. 2001 Sep;24(9):598-605. Review. No abstract available.

PMID:
11693415
6.

PGS consensus statement on management of hepatitis B virus infection--2003.

Abbas Z, Jafri W, Shah SH, Khokhar N, Zuberi SJ; Pakistan Society of Gastroenterology and G.I. Endoscopy.

J Pak Med Assoc. 2004 Mar;54(3):150-8. Review. No abstract available.

7.

Antiviral therapy in hepatitis B infection.

Thomas HC, Scully LJ.

Br Med Bull. 1985 Oct;41(4):374-80. Review. No abstract available.

PMID:
3902143
8.

[Questions to professeur Patrick Marcellin].

[No authors listed]

Gastroenterol Clin Biol. 2002 May;26(5):506-8. French. No abstract available.

9.

Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.

Marinos G, Torre F, Chokshi S, Hussain M, Clarke BE, Rowlands DJ, Eddleston AL, Naoumov NV, Williams R.

Hepatology. 1995 Oct;22(4 Pt 1):1040-9.

PMID:
7557849
10.

Treatment of hepatitis B.

Raj V.

Clin Cornerstone. 2001;3(6):24-36. Review.

PMID:
11501192
12.

Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.

Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P.

Arch Virol. 1997;142(3):535-44.

PMID:
9349299
13.
14.

Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.

Kruger M, Böker KH, Zeidler H, Manns MP.

J Hepatol. 1997 Apr;26(4):935-9.

PMID:
9126810
15.

Prevention and treatment of virus hepatitis B.

Sherlock S.

Indian J Gastroenterol. 1984 Jan;3(1):29-31. Review. No abstract available.

PMID:
6241924
16.

Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.

Craxì A, Di Marco V, Volpes R, Marra S, Rizzetto M, Rosina F, Barbera C, Bortolotti F, Crivellaro C, Iannuzzi C, et al.

Prog Clin Biol Res. 1991;364:399-404. No abstract available.

PMID:
2020715
17.

Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.

Barbera C, Bortolotti F, Crivellaro C, Coscia A, Zancan L, Cadrobbi P, Nebbia G, Pillan MN, Lepore L, Parrella T, et al.

Hepatology. 1994 Aug;20(2):287-90.

PMID:
8045488
18.

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.

Krogsgaard K, Marcellin P, Trepo C, Berthelot P, Sanchez-Tapias JM, Bassendine M, Tran A, Ouzan D, Ring-Larsen H, Lindberg J, Enriquez J, Benhamou JP, Bindslev N.

J Hepatol. 1996 Dec;25(6):803-13.

PMID:
9007706
19.

The natural history of chronic type B hepatitis in southern Italy: effect of HBV replication and of HDV infection.

Craxì A, Di Marco V, Magrin S, Scalisi I, Vassallo R, Vinci M, Genova G, D'Amico G, Maisano S, Politi F, et al.

Prog Clin Biol Res. 1987;234:153-65. No abstract available.

PMID:
3628374
20.

Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.

Cooper B.

Compr Ther. 1989 Jul;15(7):9-15. Review. No abstract available.

PMID:
2527714

Supplemental Content

Support Center